Why the study?
Primary angiosarcoma of the adrenal gland is a rare, aggressive malignancy that presents diagnostic challenges in differentiating it from more common adrenal masses.
Case Report (n=1)
Primary adrenal angiosarcoma is a rare, aggressive malignancy that requires extensive immunohistochemical workup to differentiate from other adrenal masses and carries a poor prognosis despite surgery and chemotherapy.
Supports IHC in atypical adrenal masses; leaves open evidence-based management strategies.
Primary angiosarcoma of the adrenal gland is both a rare and aggressive malignancy. Differentiating it from more common adrenal masses such as adrenal adenomas, adrenal cortical carcinomas, and metastatic carcinomas is one of several diagnostic challenges. Immunohistochemical analysis is imperative to arrive at the correct diagnosis. Treatment typically involves surgery and adjuvant chemotherapy, but prognosis remains poor.
No takes yet. Share an insight, caveat, or question.
Antao et al. (2019) conducted a case report in Adrenal Angiosarcoma (n=1). Surgical resection and adjuvant chemotherapy was evaluated on Disease progression and survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: